About
Axiom Therapeutics was a biotechnology startup focused on developing novel therapies targeting APOE4, a genetic risk factor for Alzheimer's disease.
Explore Axiom Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.